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Purpose: We report the initial French multicenter experience with the Stentor system in 
the endovascular treatment of AAAs. 
Methods: Between May 1994 and March 1996, 79 patients with AAAs were consecutively 
treated with an endovascular technique using the Stentor system. There were 71 bifur- 
cated grafts and eight straight grafts. The patients were followed-up from I to 18 months 
(mean, 5.7 months). Patient data and events were retrospectively analyzed. 
Results: No patient was lost to follow-up. There were no surgical conversions. Four 
patients died after operation (4.8%). Two of them had been considered inoperable by the 
standard technique. Four patients (4.8%) had pulmonary complications, and three had 
colonic ischemia (3.7%). Forty-five patients (57%) had postoperative f ver, and a transi- 
tory thrombocytopenia (10%) developed in eight patients. In 66 patients (83%) the 
aneurysm was immediately excluded. The exclusion was definitive in 62 (78%). In 17 
patients, there were 13 initial and six delayed endoleaks. In two of these patients, the 
initial endoleak sealed temporarily and resumed after 1 year of follow-up, requiring an 
additional straight, covered stent. Over all, seven of the leaks were treated successfully by 
an additional endovascular g aft, one leak required a htmbar artery embolization, eight 
leaks sealed spontaneously, and one leak was untreated. During follow-up, there was no 
aneurysm rupture. Two patients died of unrelated causes. 
Conclusion: The Stentor system can safely and effectively exclude AAAs in the short term. 
Careful follow-up is required to detect any delayed endoleak, nd long-term results are 
awaited to confirm the efficacy of the method in preventing AAA rupture. (J Vasc Surg 
1997;26:199-209.) 
Exclusion by an endovascular stented graft is an 
important advance in the treatment of abdominal 
aortic aneurysms (AAAs). Since the initial report by 
Parodi in 1991,1 various devices have been devel- 
oped, and some of them are already available for 
clinical application. 2 4 Among the technologic prob- 
lems encountered were the need for a reliable intro- 
ducer and for a bifurcated prosthesis. An inadequate 
introducer may result in trauma to access vessels and 
in blood loss. Straight stented grafts have limitations: 
the aneurysm should have a sufficient length of distal 
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neck above the aortic bifurcation, which is relatively 
rare, or the stent graft should be deployed in the 
aorta and one iliac artery, with occlusion of the con- 
tralateral common iliac artery and femorofemoral 
bypass grafting to revascularize the excluded limb. 
The Stentor system (Minimally Invasive Technol- 
ogies, Mintec, La Ciotat, France) consists of an inno- 
vative introducer and delivery system and a variety of 
endovascular grafts, comprising straight, tapered, 
and bifurcated grafts (Mialhe Stentor bifurcation). 
The first human implantation took place in France in 
May 1994. The present series reports the data col- 
lected from the group of French vascular surgeons 
who have used the Stentor system from May 1994 to 
March 1996. All of  the implants were performed in 
collaboration with one of the authors (C.M.). The 
purpose of this retrospective multicenter study is to 
report the preliminary results of all 79 AAAs treated 
consecutively with the Stentor endovascular graft in 
France during this period of time. 
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Fig. 1. Mialhe Stentor bifurcation with two parts: aor- 
toiliac shaft and contralateral limb graft. Left, Mintec sys- 
tem. Note suture on limb of graft. Right, Vanguard Boston 
Scientific system without suture. 
Stentor endovascular graft 
The Stentor device is a flexible, fully supported, 
self-expanding endovascular graft constructed from 
thermal-memory nitinol monofilament wire an- 
nealed into a tubular zig-zag configuration and cov- 
ered by a low-permeability polyester fab ic. 
The self-expandable nitinol stent assumes its 
original shape when heated above its transition tem- 
perature (27 ° C). Nitinol (Nickel tantalum alloy) in- 
travascular stents has been shown to be reliably and 
safely deployed in the vascular system of animals. <6 
The proximal and distal ends of the stent carry ra- 
diopaque platinum markers. The proximal part of the 
stent frame is not covered by fabric and carries addi- 
tional barbs to allow better fixation to the aortic wall 
and minimize the chance of migration. The Stentor 
system comprises three basic designs, two tubular 
(straight and tapered) and one bifurcated (Mialhe 
Stentor bifurcation). The bifurcated esign (Fig. 1), 
covered by fabric sewn at leg and bifurcation level, 
comprises two components, which are introduced 
separately into the aorta: the aortoiliac component 
(Stentor-bifurcation), which is introduced through 
an 18F (inside diameter) delivery system, requires a 
femoral cut-down approach; and the second iliac leg 
(Stentor iliac; STI) is introduced percutaneously 
through a 10F (inside diameter) introducer sheath. 
The two components are mated into the infrarenal 
aorta under fluoroscopic guidance (Fig. 2). If  neces- 
sary, both device limbs can be extended to the re- 
quired length by the addition of polyester-covered 
nitinol stents (Cragg Endopro). 
The available diameters were 22 to 26 mm for the 
aortic segment and 10 and 12 mm for the iliac 
segment. Initially, a single length of 140 mm was 
available, which was relatively short, and subse- 
quently 153 and 165 mm devices were manufactured 
to reduce the need for extensions. 
PAT IENTS AND METHODS 
The patients included in this series were selected 
through acollaboration between the responsible sur- 
gical and ancsthesiologic teams and one of the inves- 
tigators (C.M.). The Appendix lists the surgeons 
who contributed. Patient inclusion took into ac- 
count the operative risk, and the morphologic fea- 
tures and the dimensions of  the aneurysm. 
Patients were categorized according to thc crite- 
ria of the American Society of Anesthesiology (ASA). 
The very first procedures of the series included pa- 
tients who were considered to be inoperable by con- 
ventional methods or who were at a high operative 
risk; howcver, later on, with an improved experience, 
patients who were good surgical candidates were also 
selected. The preoperative assessment included a 
computed tomographic (CT) scan with injection for 
measurement of the anteroposterior and transverse 
diameters of the aneurysm, the infrarenal neck, and 
the lilac arteries, and to determine the existence and 
location of intraaneurysmal thrombus. Aortograms 
with anteroposterior and lateral views were obtained 
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Fig. 2. Stentor implantation procedure. A, Femoral introduction of catheter containing 
aortoiliac shaft and femoral puncture for introduction of STI system. B, Intraaortic delivery of 
aortoiliac shaft. C, Placement and anchorage of STI. D, Final modeling of system with balloon 
inflation. 
with a marker catheter to measure the infrarenal 
neck, the length of the aorta from the renal arteries 
to the aortic bifurcation, and the length of the com- 
mon iliac vessels to the iliac bifurcation. The patency 
of the renal, mesenteric, and hypogastric arteries was 
screened carefully. Because of the available sizes and 
configurations of the endovascular g afts, only aneu- 
rysms with a proximal neck of at least 15 mm m 
length and with a diameter of 25 mm or less were 
included. The diameter of the common iliac arteries 
could not be greater than 12 mm. According to their 
extent, the aneurysms were categorized into six 
groups from A to F (type A, aneurysms limited to the 
middle infrarenal aorta; type B, aneurysms involving 
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Table I. Preoperative risk 
factors--79 patients 
Risk factors No. % 
Hypertension 38 48 
Coronary disease 36 46 
Smoking 31 39 
Other arterial disease 29 37 
Cardiac disease 27 34 
Respiratory disease 20 25 
Obesity 22 28 
Previous laparotomy 18 23 
Renal disease* 12 15 
Diabetes mellitus 6 8 
Liver disease 2 3 
Other1" 16 20 
*One patient with ongoing dialysis. 
J'Pafient could have more than one risk factor. 
the aortic bifurcation; type C, aneurysms involving 
the proximal part of the common iliac arteries; type 
D, aneurysms involving the distal part of the com- 
mon lilac arteries; type E, aneurysms with an infrare- 
nal neck shorter than 15 mm; type F, aneurysms that 
extended to the external i iac arteries). Only type A 
to D aneurysms were considered for this technique. 
All patients were informed of the detail of the 
procedure and of the lack of long-term efficacy study. 
The implant procedures were carried out in oper- 
ating rooms equipped for vascular and endovascular 
surgery, with a portable fluoroscopic C-arm device 
that could provide digitized images and road map- 
ping. Most participating surgical teams had good 
experience in current endovascular techniques, par- 
ticularly angioplasty and endovascular stent deploy- 
ment for occlusive disease. The implant procedures 
were carried out with the patient under general anes- 
thesia, except for three patients who were given epi- 
dural anesthesia. Whenever possible, the side of the 
surgical groin incision was chosen according to the 
location of the thrombus in the aneurysmal sac. It 
was thought hat the risk of fragmentation of the 
parietal thrombus within the aneurysm by the tip of 
the delivery system would be minimized if the great- 
est thickness of the clot remained untouched. The 
second criterion of choice was the aspect of the iliac 
arteries, the Stentor bifurcation being more easily 
pushed up in straight and nonstenosed arteries. 
Data gathering began in January 1996. Demo- 
graphic data, risk factors, characteristics of the aneu- 
rysm, details of the procedure, and postoperative 
assessment were obtained from the patient's records. 
All patients were followed-up regularly. Clinical ex- 
amination, an angiogram, and a CT scan with injec- 
tion were obtained in the first postoperative month. 
Clinical follow-up, Duplex scan examination, and 
CT scan were also planned at 3 months, at 6 months, 
and then every 6 months thereafter. In all cases of a 
persistent leak or a new leak, a repeat angiogram was 
obtained to decide on complementary endovascular 
treatment or surgical conversion. 
RESULTS 
Seventy-nine patients with abdominal aortic an- 
enrysms who were treated consecutively with Stentor 
endovascular grafts between May 31, 1994, and 
March 7, 1996, were included in this series. There 
were 75 men and four women. The patients' ages 
ranged from 45 to 89 years (average, 69.5 -+ 6.75 
years). 
The risk factors are presented in Table I. Forty- 
one patients (51.4%) were classified ASA 2, 26 pa- 
tients (32.9%) were classified ASA 3, and 12 patients 
(15%) were classified ASA 4. In the ASA 4 group, 
two patients had painful aneurysms of more than 50 
mm in diameter that were considered inoperable by 
conventional methods. Four of the 79 patients had 
type A aneurysms, 24 had type B aneurysms, 37 had 
type C aneurysms, and 14 had type D aneurysms. 
Seventy aneurysms were asymptomatic, seven were 
painful, and two had peripheral embolism. The aver- 
age diameter was 51.28 _+ 10.87 mm (range, 30 to 
82 mm). The diameters were between 30 and 39 mm 
in four patients, less than 50 mm in 21 patients, and 
more than 50 mm in 54 patients. Among four pa- 
tients who had small aneurysms, two had lower limb 
embolism, one was painful with contrast medium 
within the aneurysmal thrombus on CT scan, and the 
remaining patient had a large associated common 
lilac aneurysm. 
The implants included four straight aortic endo- 
vascular grafts (5%), four tapered endovascular g afts 
(5%), with concomitant cross-over femorofemoral 
bypass in three patients, and 71 bifurcated endovas- 
cular grafts (90%). In 37 patients, supplementary 
straight endovascular g afts were added to one of the 
iliac branches to obtain a sufficient length to exclude 
the anenrysms. The need for additional grafts was 
more frequent in the early experience because of the 
single availability of 140 mm grafts. 
In 66 patients (83%), the surgical approach was 
from the right groin. Progression of the introducer 
was difficult in 27 patients (34%); in 23 patients this 
was a result of iliac artery tortuosity, and in four 
patients it was a result of calcified stenosis. The an- 
gles between the axis of the infrareual neck and the 
axis of the adjacent above aorta on preoperative an- 
giograms were less than 45 degrees in 64 patients, 
JOURNAL OF VASCULAR SURGERY 
Volume 26, Number 2 Mialhe, Amicabile, and Becquemin 203 
between 45 and 75 degrees in 12 patients, and 
greater than 75 degrees in three patients. An angle 
greater than 80 degrees constitutes a limit to the 
method because the proximal end of the endovascu- 
lar graft may dislodge and cause a proximal leak. The 
second iliac limb (STI) was implanted in 67 patients 
percutaneously through the contralateral femoral ar- 
tery. In four patients, direct retrograde catheteriza- 
tion of the iliac stump of the aortoiliac omponent 
was impossible. A guidewire was then introduced 
into the aortoiliac graft from the surgical cut-down 
in three patients and from a brachial approach in one 
patient and was pushed into the nonstented iliac 
artery. The tip of the guidewire Was then caught with 
a basket catheter and pulled down through the per- 
cutaneous introducer. Then the STI was inserted in 
the usual way. The endovascular g aft excluded from 
the main blood flow one hypogastric artery in 10 
patients and both hypogastric arteries in one patient. 
In ten patients, the inferior mesenteric artery was 
considered patent on the preoperative arteriogram. 
No renal arteries were covered by the covered part of 
the stented graft. The average volume of the contrast 
medium was 270 + 67.8 ml. It was 135 + 21.2 ml 
(range, 120 to 150 ml) for straight endovascular 
grafts, 270 -+ 47.8 ml (range, 200 to 300 ml) for 
tapered endovascular g afts, 251 _+ 64.8 ml (range, 
150 to 400 ml) for bifurcated grafts, and 294 +- 60.8 
ml (range, 200 to 420 ml) for grafts that required 
additional stents. 
Additional surgical or endovascular procedures 
were required in 24 patients (30%); three were cross- 
over femorofemoral bypass procedures to restore 
flow to the limb excluded by a unilateral aortoiliac 
endovascular graft, and 21 procedures (26%) were 
performed to facilitate the insertion of the endovas- 
cular graft. These included 15 balloon angioplasty 
procedures for iliac artery stenosis, four endarterec- 
tomies of the common femoral artery, and two ipsi- 
lateral iliac grafting procedures. 
Immediate results 
There was no implant failure nor any surgical 
conversion. Four deaths occurred uring hospitaliza- 
tion (4.8%). The first death occurred in a patient in 
whom acute respiratory distress yndrome developed 
72 hours after the implantation; the patient died in 
the fifth week after the procedure as a result of 
nosocomial respiratory infection. The second death 
occurred in a patient who had a type D aneurysm 
that extended close to both hypogastric arteries. The 
hypogastric artery on the right side was excluded by 
an aortouniiliac endovascular g aft. On the left side, 
it was planned to reimplant the hypogastric artery in 
the external iliac artery. During the dissection, the 
common iliac vein was inadvertently torn and could 
not be controlled until after the hypogastric artery 
was ligated. This patient died as a result of blood loss 
and of pelvic and colonic ischemia during the proce- 
dure. The third death occurred in a patient who had 
a large, painful type D aneurysm as well as severe 
respiratory and cardiac insufficiency. The procedure 
required the crossing of one hypogastric artery. The 
patient died on the third postoperative day from 
multiorgan failure as a result of low cardiac output 
and buttock ischemia. The fourth death occurred in 
an 80-year-old patient receiving dialysis for chronic 
renal insufficiency who had a painful aneurysm. 
Death occurred 48 hours after the operation after 
collapse during a dialysis session. Of these four pa- 
tients, two had painful aneurysms and had been re- 
jected for conventional surgery. 
General complications. There were four respi- 
ratory complications (4.8%). One occurred in a pa- 
tient who died and has already been described above. 
The three others, all in patients with severe respira- 
tory insufficiency, involved infectious pneumonia 
that was successfully treated with antibiotics.. There 
were no coronary complications. Colon or pelvic 
ischemia developed in four patients. One case was a 
grade 1 left colon ischemia. It improved under med- 
ical treatment. This patient had a type B aneurysm, 
with patent inferior mesenteric and hypogastric ar- 
teries. The second case of ischemia occurred in a 
patient who previously had undergone duodenopan- 
createctomy for tumor of the ampulla of Vater and 
radiotherapy of the pelvis for prostate cancer. This 
patient required a left colectomy with a temporary 
colostomy. Three months later the continuity of the 
colon was restored. The third and fourth cases oc- 
curred in the patients previously described who died 
after exclusion of hypogastric artery. On the preop- 
eratiye angiogram, the patency of the inferior mesen- 
teric artery was uncertain. 
Two of 12 patients with preoperative r nal insuf- 
ficiency (only one out of the 12 required preopera- 
tive dialysis) had impaired renal function after the 
operation; in one of these patients the creatine level 
returned to its preoperative value after a few days, 
but the second required ongoing dialysis. The total 
amount of contrast medium in these two patients was 
280 ml and 420 ml, respectively. 
Forty-five patients had fever (>38 ° ) after the 
implantation for i to 4 days. In 10 patients (12.6%) 
the temperature rose to 40 ° C. In nine of these 
patients, no infection was detected. One patient had 
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Table II. Description and evolution of endoleaks 
Patient Date Type Location Cause 
Total follow-up 
V~me 
Evolution resolved Situation Duration 
Initial 
1 * Procedure Minor Limb Fabric 
2 Procedure Major Iliac Mismatch 
3 Procedure Major Proximal Mismatch 
4 Procedure Minor Limb Fabric 
5 Procedure Major Proximal Tortuosity 
6 Procedure Minor L imb Fabric 
7* Procedure Minor Limb Fabric 
8 Procedure Major Proximal Mismatch 
9 Procedure Major Iliac Mismatch 
10 Procedure Minor Limb Fabric 
11 Procedure Major Iliac Mismatch 
12 Procedure Major Proximal Tortuosity 
13 Discharge Minor Limb Fabric 
Delayed 
1 * 1 yr Minor Limb Fabric 
7* 1 yr Minor Limb Fabric 
14 3 mo Minor Limb Fabric 
15 6 mo Perigraft Lumbar artery 
16 6 mo Minor Limb Frabric 
17 6 mo Perigraft Iliac Mismatch 1"
Spontaneous seal 1 mo Releak 1 yr 
Covered stent 4 mo Death/sealed 1 yr 
Not treated - -  Death/unsealed 3 mo 
Spontaneous seal 1 wk Sealed 1 yr 
Spontaneous seal 1 wk Sealed 6 mo 
Spontaneous seal i yr Sealed 1 yr 
Spontaneous seal 1 wk Releal< I yr 
Cuff extension 1 mo Sealed 1 yr 
Spontaneous seal 2 days Sealed 9 mo 
Covered stent 9 mo Sealed 1 yr 
Spontaneous seal 1 mo Sealed 6 mo 
Spontaneous seal 3 mo Sealed 9 mo 
Spontaneous seal 1 mo Sealed 6 mo 
Covered stent 1 yr Sealed 1 yr 
Covered stent 1 yr Sealed 18 mo 
Covered stent 1 yr Sealed 18 mo 
Embolization 9 mo Sealed 1 yr 
Covered stent 1 yr Sealed 18 mo 
Spontaneous seal 1 yr Sealed 1 yr 
*Patients 1 and 7 had transitory sealings. See text. 
tProgressive enlargement of the common iliac artery. 
a single blood culture positive for Streptococcus aerugi- 
nosa. Transitory thrombocytopenia (<80,000/m 3)
was observed in eight patients (10%). 
Local vascular complications. There were six 
hematomas (7.5%). Two of these were associated 
with a percutaneous approach and four with a surgi- 
cal approach. These complications required surgical 
repair in four cases (4.8%). All were observed under 
conditions of frank hypocoagulability, with the plate- 
let level less than 60,000/mm 3, activated partial 
thromboplastin time greater than 120 seconds, and 
international normalized ratio more than 4. A blood 
transfusion was necessary in five patients (6.3%), to 
compensate intraoperative h morrhage in one and to 
provide blood coagulation factors in four. A groin 
infection occurred in one patient on the side of the 
surgical approach. The wound healed after debride- 
ment and drainage. 
Vascular complications. There were five throm- 
boses (6.3%) during the procedure: two iliac 
branches of the aortoiliac omponent, wo external 
iliac arteries distal to the endovascular g aft, and one 
iliofemor*al bypass graft implanted to facilitate the 
introduction of the stented graft. These five throm- 
boses were all successfully treated uring the periop- 
erative period by thrombectomy with a Fogarty cath- 
eter. One popliteal embolism occurred on the side of 
the percutaneous approach (1.2%) during the endo- 
vascular procedure. It was treated with surgical em- 
bolectomy. There was no amputation. 
Midterm results 
No patient has been lost to follow-up. The aver- 
age follow-up has been 5.7 + 4.7 months, with a 
range of 1 to 18 months. The median follow-up was 
4.2 months. 
Among the 75 patients who survived the proce- 
dure, two deaths occurred during follow-up. One 
death occurred 3 months after the implantation as a 
result of a pulmonary infection in a patient with 
major respiratory insufficiency. The second death oc- 
curred 12 months after implantation. The cause was 
not determined. The late general complications in- 
cluded renal insufficiency in one patient hat devel- 
oped 3 months after the implantation. Renal biopsy 
showed cholesterol crystal embolism. This patient 
had major atherosclerosis of the thoracic and abdom- 
inal aorta; however, a CT scan carried out immedi- 
ately before the discharge of the endovascular p oce- 
dure showed no sign of renal ischemia. This patient 
was later placed on chronic dialysis. 
There were no late nonvascular complications. 
Two patients had late thrombosis of the contralateral 
iliac limb (STI). One of these remained asymptom- 
atic at the eighth month, and no procedure was 
carried out to restore flow. A review of the early 
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Fig. 3. A, Preoperative angiogram of 68-year-old patient with large AAA. Graduated catheter 
allowed precise d termination f size and length of prosthesis. B, Postoperative angiogram of 
same patient shows prosthesis and absence of endoleak within a eurysmal pouch. 
postoperative angiogram showed a stenosis at the junc- 
tion between the Stentor bifurcation and the STI. The 
second patient had claudication caused by an STI 
thrombosis aftcr 15 months. A cross-over femorofemo- 
ral bypass procedure was successfully performed. 
Effect on the anettrysmal sac 
Leaks and diameters were assessed by angiogra- 
phy in all patients during the procedure, and then by 
Duplex scan examination and CT scan with injection 
during follow-up. Seventy-nine patients have under- 
gone postoperative angiography, and 76 have under- 
gone a CT scan at 1 month. In 55 patients, at least a 
CT scan was available between the third and the 
eighteenth postoperative month. The diameter of 
the aneurysms were considered on the latest available 
CT scan, which were five patients at 3 months, 16 at 
6 months, nine at 9 months, 22 at I2 months, and 
three at 18 months. In this subgroup of patients, the 
mean aneurysm diameter was 49.3 +- 9.3 mm before 
the operation, as compared with 45.9 2 I0.9 mm on 
the latest available CT scan (p = 0.00002, t test 
paired values). 
Analysis and evolution of  leaks 
Patients with leaks are summarized in Table II. 
Initial leaks. In 66 of the 79 patients, there was 
an immediate seal and the aneurysm was totally ex- 
cluded (83.5%; Fig. 3). Thirteen patients had an 
initial residual leak (16.5%) that was seen either dur- 
ing the operation on the completion arteriogram or 
before discharge. Major leaks Were defined as direct, 
and massive opacification of the aneurysmal sac and 
minor leaks were defined as faint opacification of the 
aneurysmal sac on late films. The location of the leaks 
was determined by arteriography. Seven leaks were 
major. Four of the major leaks were at the proximal 
neck. In two of these cases, the leaks sealed sponta- 
neously (checked by CT scan at 7 days and at 1 
month, respectively) and remained sealed at late fol- 
low-up. In the two remaining cases, the leak per- 
sistcd. One of these patients died in the third month 
of bronchitis and respiratory insufficiency. The other 
patient was successfully treated with a new tubular 
stented graft. Three major leaks were located at the 
extremity of the iliac branch. Two leaks sealed spon- 
taneously at 2 days and 1 month, respectively. In the 
third patient, a new iliac endovascular g aft was suc- 
cessfully implanted in the fourth month. 
Six leaks were minor. They were caused by tears 
in the polyester at the suture line along the iliac limb, 
as demonstrated by the guidewire passing through 
the fabric during attempts to locate the leak. Five 
minor leaks sealed spontaneously, at 1 week in one 
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Fig. 4. CT scan 3 months after operation in 62~year-old patient treated with Mialhe Stentor 
bifurcation shows endoleak arising from right limb of graft. 
case and at 1 month in three cases. In the remaining 
case, sealing was observed at 1 year. In one patient 
the leak persisted, necessitating the implant of  a new 
covered endovascular g aft in the right branch of the 
Stentor device. No retrograde l ak through the ex- 
cluded hypogastric arteries was observed in this se- 
ties. 
Of  the total of 13 initial leaks, one patient died 
before resolution of the leakage, three were treated 
successfully by additional endovascular grafts, and 
nine scaled spontaneously. Among these latter pa- 
tients, two had recurrence of the leakage at i2 and 
18 months, respectively, after the operation. The 
cause of spontaneous ealing and recurrence re- 
mained uncertain; however, it could have been 
caused by a formation of parietal thrombus that lysed 
secondarily. 
Delayed leaks. CT scan with injection during 
follow-up disclosed six cases of delayed leakage in the 
aneurysmal sac (one at 3 months, three at 6 months, 
and two at 12 months; Fig. 4). Two of these leaks 
were recurrent and have already been described 
above; four were detected uring follow-up. These 
delayed leaks were of two types. 
Paraprosthetic leaks (n = 2). In one patient, the 
aneurysmal sac was opacified via a lumbar artery,, 
which was identified on an arteriogram at 6 months 
and treated with embolization at 9 months. In the 
remaining case, the leak was a result of a discrepancy 
of the size of one limb of  endovascular g aft and the 
iliac artery. This leak, which was disclosed on a CT 
scan at 6 months, was probably caused by progressive 
enlargement of the iliac artery at the site of  the distal 
part of the endovascular g aft. 
Transprosthetic leaks (n = 4). These leaks were a 
result of a rupture of  the polyester at the suture line 
on the limb of the graft. These four patients were 
treated with new covered endovascular g afts. 
DISCUSSION 
Our series confirms the recent publication of 
Blum et al.7 that the Stentor system can be used for 
the endovascular t eatment of abdominal aortic an- 
eurysms. It is noteworthy that the cases described 
herein are an initial experience that included all im- 
plantations ince the first one performed in May 
1994. Perioperative data show the feasibility and 
safety of the device. The Stentor system offers a 
variety ofcndovascular g afts, the most interesting of 
which is the bifurcated graft. One advantage of bifur- 
cated grafts as compared with straight prostheses is 
their availability for a larger proportion of patients. 
With straight prostheses in the Endovascular Tech- 
nologies (EVT) study, only 10% of the patients as- 
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sessed for endovascular t eatment could be includ- 
ed. 3,4 The majority of noninclusions were caused by 
an inferior neck that was too short. With bifurcated 
endovascular grafts, between 30% and 50% of ab- 
dominal aortic aneurysms can be treated. 7 Among 
the different devices available for clinical evaluation, 
the second generation of bifurcated Chuter endovas- 
cular grafts has also given promising results, s How- 
ever, the graft is not fully supported, which explains 
the risk of twist of the limbs or the need for routine 
adjunctive stenting as opposed to the Stentor system. 
In this series, the postoperative mortality rate was 
4.8%. Excluding the two patients who were consid- 
ered to be unacceptable for surgery, the mortality 
rate of this series was only 2.6%. General nonfatal 
complications occurred in 10.1% of patients, and the 
overall minor and major complications rate was 31%. 
These figures are close to those obtained by conven- 
tional surgical series. 9,~° 
The hope of a better outcome offered by this 
less-aggressive t chnique, particularly in high-risk 
patients, is not entirely fulfilled. The mortality rate 
with patients graded ASA 3 and 4 was 25%, and three 
of the four deaths in this series occurred in this group 
of patients. Thus, in our opinion, the suitability for 
endovascular t eatment of AAAs remains more re- 
lated to the morphologic haracteristics of the aneu- 
rysm and the iliac arteries and to the available range 
of calibers of endovascular g afts than by the general 
status of the patient) ~ This opinion is reinforced by 
the results of May et al., ~2 who showed that the 
mortality/morbidity rate of failed endovascular im- 
plantations and subsequent standard operation was 
increased. During the postoperative course, two 
events have not received a clear explanation--the 
fever that appeared in 57% of patients and the coag- 
ulation disorders een in 10%. These observations of 
inflammatory esponse were also made by Norgren et 
al) a In a series of 154 patients, Blum et al. 7 reported 
fever in 87 (56%). Swartbol et al. ~4 found higher 
levels of tumor necrosis factor-alpha in a group of 
patients treated with endovascular g afts as compared 
with patients who were treated with open surgery. 
Fever and thrombocytopenia m y also be related to 
the thrombosis in the excluded aneurysm, which 
involves coagulation proteins and platelets. In this 
series, all patients who had this postexclusion syn- 
drome (fcver-thrombocytopenia) h d outright ex- 
clusion of the aneurysm. 
In our series, local complications were prevalent 
when additional surgical procedures were performed 
to enable exclusion of the ancurysm. These observa- 
tions are similar to the series of May et al., ~2 in which 
the rate of perioperative local complications reached 
32%. Tortuosity, stenosis, and calcification of the 
iliac arteries or extended aneurysms increased the risk 
of intraoperative problems and thus the rate of post- 
operative complications. In the present series, only 
one patient had a distal embolism (1.2%), as com- 
pared with rates that vary from 5.7% to 16% in certain 
series. 12;15,16 The low profile of the Stentor intro- 
ducer, the choice of the principal access ide accord- 
ing to the location of thrombus in the aneurysm sac, 
and the avoidance of extensive aortic instrumenta- 
tion s may account for this low rate. In our series, 
there was no intraoperative blood loss through the 
introducer, which is blood-tight and constitutes a
major advantage of the Stentor system. Transfusions 
were required in only five patients, as a result of 
surgical difficulties to control one hypogastric artery 
in one patient and as a result of a major thrombocy- 
topenia in four patients. Colon and pelvic ischemia 
occurred in four patients. In two of these patients, 
internal iliac occlusion was necessary to exclude aor- 
toiliac aneurysms. Although it remains possible to 
safely exclude hypogastric arteries, as we have done 
in nine more patients, this option should be reserved 
to very selected patients a7 with a fully patent con- 
tralateral hypogastric artery and a superior mcsen- 
teric artery that is free of disease. 
With complete xclusion, the aneurysm generally 
diminishes in size within 2 to 24 months of follow- 
up. 7,18 In our series, we also observed a significant 
reduction in the diameters of the aneurysms (mean 
difference, 3.49 mm), which is the best marker of the 
technical success, and no rupture occurred during 
clinical follow-up. 
Leak remains a major problem of endovascular 
grafting. We observed a 16.5% rate of early leaks, 
which is close to the figure of Blum ctal . ,  7 who 
reported early leaks in 13.7% of patients. With other 
devices, particularly those that are not manufactured, 
higher rates have been reported: Parodi, ~5 20%; Ed- 
wards et al., 3 27%; Moore et al., 4,19 60%; May et al.,~2 
26.5%; Chuter et al., s 23%; Matin and Veith,16 45%; 
Murphy et al., 2° 34%; and Nasim et al., 21 30%. The 
leaks are of various origins. Some leaks are caused by 
a mismatch between the graft and the arterial wall at 
the extremities of the graft. Precise preoperative de- 
termination of lengths and diameters of the aneu- 
rysm and necks are determinant for a successful im- 
plantation. It also sounds sensible to oversize slightly 
the endovascular g afts and to avoid implantation i  
aorta with acute angle. 7
Certain of our leaks were caused by fabric defects. 
In ten cases, the leak was caused by a tear of the 
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polyester at the suture line as it was confirmed by 
catheter exploration. This was also reported by Blum 
et al., 7 who observed 12 cases of tear in the polyester 
out of  20 leaks. The new Boston Scientific Vanguard 
system (Meadox, Boston Scientific Corporation, 
Oakland, N.J.), which uses the original Stentor de- 
sign with a new low-water permeability polyester 
fabric that does not require suturing, is expected to 
eliminate these complications. Leaks into the aneu- 
rysmal sac may also arise from back-bleeding of 
patent lumbar, sacral, or inferior mesenteric arteries. 
They are mostly minor leaks. 
The evolution of the leaks is variable. We have 
observed spontaneous sealing of leaks at the ends of  
the stent. Spontaneous sealing may be a result of the 
slow adaptation of the nitinol frame to the arterial 
wall, which may be an advantage of self-expandable 
stents as opposed to balloon-expanding stents. How- 
ever, sealing may also follow slow thrombus forma- 
tion between the arterial wall and the graft. This type 
of sealing is hazardous. Similar to Parodi's experi- 
ence, 22 we observed two cases of  recurrence. This is 
also a reason to avoid the application of the stent on 
an arterial wall covered by thrombus. Leak from the 
collateral vessels may also undergo spontaneous 
thrombosis, 8 and their incidence on the evolution of 
the aneurysm sac is not perfectly lmown yet. 
Of concern is the possibility that the dilatation 
process may continue at the aneuDTsm necks t8 de- 
spite a shrink of the maximal diameter of the AAA. 
This enlargement could lead to delayed leakage, as 
we have observed in one case (at the iliac level), and 
even to migration of the system. Only very precise 
and repeated assessments by CT scan during fol- 
low-up will answer this important question. 
Persistence or recurrence of endoleak that main- 
tains high pressure in the sac must not be left un- 
treated because cases of  rupture have been report- 
ed. 18 Treatment of leak may require an additional 
stented graft inserted in the first conduit, as we have 
clone successfully in seven patients, or embolization 
in case of collateral back-flow. However, when the 
endovascular exclusion fails, surgical conversion is 
required. Conversion has not yet been necessary in 
the present series, and was needed in only three 
patients out of 154 in the series by Blum et al.7 
CONCLUSION 
Endovascular stented grafts offer a real hope for 
safe, effective, less-invasive treatment of abdominal 
aornc aneurysms. The Stentor system and second 
generation developments are relatively simple to im- 
plant as long as the operating team is trained in 
endovascular techniques and the patient is appropri- 
ately selected, the best criterion of which being the 
anatomical morphologic features. To answer the im- 
portant question of long-term therapeutic effective- 
ness, longer follow-up and prospective studies are 
required. This new technology represents a revolu- 
tion in the treatment of AAAs, a revolution that is 
expected to be accepted by conventional vascular 
surgeons and that will require special training and 
quality control before entering into routine applica- 
tion. 
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